eighty-four evaluable patients with advanced hodgkin 's disease ( stages iib , iiia age greater than 35 or mixed cellularity or lymphocyte depletion histology , iiib , iva , and ivb ) were treated with alternating monthly mopp and adriamycin , bleomycin , dacarbazine , and vinblastine ( abdv ) .
C0019829
hodgkin 's disease
C0042670
vinblastine